OncoAlert (@oncoalert) 's Twitter Profile
OncoAlert

@oncoalert

🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨

ID: 1109128247789395968

linkhttp://www.OncoAlert360.com calendar_today22-03-2019 16:22:35

103,103K Tweet

38,38K Followers

157 Following

OncoAlert (@oncoalert) 's Twitter Profile Photo
OncoAlert
@oncoalert

a month ago

NEWS FROM INDUSTRY: SOURCE Astra Zeneca POTOMAC Update Astra Zeneca reports that the POTOMAC Phase III trial demonstrated that adding one year of durvalumab to standard Bacillus Calmette-Guérin (BCG) induction and maintenance therapy significantly improved disease-free survival

NEWS FROM INDUSTRY: SOURCE Astra Zeneca POTOMAC Update Astra Zeneca reports that the POTOMAC Phase III trial demonstrated that adding one year of durvalumab to standard Bacillus Calmette-Guérin (BCG) induction and maintenance therapy significantly improved disease-free survival